Utility of [18 F]FLT-PET to assess treatment response in trastuzumab-resistant and trastuzumab-sensitive HER2-overexpressing human breast cancer xenografts.

Whisenant JG, McIntyre JO, Peterson TE, Kang H, Sánchez V, Manning HC, Arteaga CL, Yankeelov TE
Mol Imaging Biol. 2015 17 (1): 119-28

PMID: 25034624 · PMCID: PMC4311727 · DOI:10.1007/s11307-014-0770-z

MeSH Terms (16)

Animals Antibodies, Monoclonal, Humanized Breast Neoplasms Dideoxynucleosides Drug Design Drug Resistance, Neoplasm Female Humans Immunohistochemistry Ki-67 Antigen Mice Neoplasm Transplantation Positron-Emission Tomography Receptor, ErbB-2 Trastuzumab Xenograft Model Antitumor Assays

Connections (4)

This publication is referenced by other Labnodes entities: